InMed Pharmaceuticals (INM) Operating Income (2021 - 2025)
InMed Pharmaceuticals (INM) posted quarterly Operating Income of -$2.1 million for Q4 2025, up 6.72% year-over-year from -$2.0 million in Q4 2024, and down 15.49% quarter-over-quarter from -$1.8 million in Q3 2025.
InMed Pharmaceuticals (INM) Operating Income (2021 - 2025) Analysis & Trends
InMed Pharmaceuticals' Operating Income history runs 5 years deep, the most recent figure standing at -$2.1 million for Q4 2025.
- In Q4 2025, Operating Income rose 6.72% year-over-year to -$2.1 million; the TTM figure through Dec 2025 stood at -$8.3 million (down 5.49% YoY), while the FY2025 annual figure was -$7.9 million, up 3.05% from the prior year.
- Operating Income for Q4 2025 stood at -$2.1 million, down from -$1.8 million in the prior quarter.
- The five-year high for Operating Income was -$485150.0 in Q2 2023, with the low at -$6.5 million in Q2 2022.
- The 5-year median for Operating Income is -$2.2 million (2023), against an average of -$2.5 million.
- The sharpest annual moves came in 2023 and 2024: Operating Income surged 92.56% in 2023, then sank 319.3% in 2024.
- InMed Pharmaceuticals' Operating Income stood at -$4.3 million in 2021, then surged by 48.66% to -$2.2 million in 2022, then increased by 25.7% to -$1.6 million in 2023, then slumped by 37.03% to -$2.3 million in 2024, then grew by 6.72% to -$2.1 million in 2025.
- Business Quant data shows INM's Operating Income at -$2.1 million in Q4 2025, -$1.8 million in Q3 2025, and -$2.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | InMed Pharmaceuticals | 6.52 Mn | 1.28 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.10 Mn |
| Sep 30, 2025 | -1.82 Mn |
| Jun 30, 2025 | -2.47 Mn |
| Mar 31, 2025 | -1.91 Mn |
| Dec 31, 2024 | -2.25 Mn |
| Sep 30, 2024 | -1.73 Mn |
| Jun 30, 2024 | -2.03 Mn |
| Mar 31, 2024 | -1.84 Mn |
| Dec 31, 2023 | -1.64 Mn |
| Sep 30, 2023 | -2.67 Mn |
| Jun 30, 2023 | -485,150.00 |
| Mar 31, 2023 | -2.15 Mn |
| Dec 31, 2022 | -2.21 Mn |
| Sep 30, 2022 | -3.58 Mn |
| Jun 30, 2022 | -6.52 Mn |
| Mar 31, 2022 | -3.54 Mn |
| Dec 31, 2021 | -4.31 Mn |